Cassava Sciences at the Alzheimer's Association International Conference

Jul 29, 2021
11:00 AM EDT

Oral Presentation: Encouraging Interim Results at 9 Months from an Open-label Study of Simufilam in Alzheimer’s Disease

Supporting Materials